Search Results - "Delgado, Diego Hernán"

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance by Aghel, Nazanin, Delgado, Diego Hernan, Lipton, Jeffrey Howard

“…Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment and outcomes of chronic myeloid leukemia (CML). Despite their significant impact on the…”
Get full text

Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up by Aghel, Nazanin, Lipton, Jeffrey Howard, Atenafu, Eshetu G., Kim, Dennis Dong Hwan, Delgado, Diego Hernan

“…The present study evaluated the incidence of cardiovascular events (CVEs) in 63 chronic myeloid leukemia (CML) patients after long-term exposure to nilotinib…”
Get full text

Progress in mechanical circulatory support by Delgado, María S, Bernabeo, Gustavo, Delgado, Diego Hernán

“…Mechanical circulatory support is an important aspect of the management of patients with severe heart failure. Such support improves survival when treatment…”
Get full text

Exercise Intervention for Patients With Transthyretin Amyloid Cardiomyopathy (EXCITE-ATTR-CM) Pilot Study by Rivera-Theurel, Fernando, Oh, Paul, Thavendiranathan, Paaladinesh, Laundos, Rebecca, El-Rayes, Malak, Nugaeva, Natalia, Delgado, Diego Hernan

Get full text

Exercise Intervention for Patients With Transthyretin Amyloid Cardiomyopathy (EXCITE-ATTR-CM) Pilot Study by Rivera-Theurel, Fernando, Oh, Paul, Thavendiranathan, Paaladinesh, Laundos, Rebecca, El-Rayes, Malak, Nugaeva, Natalia, Delgado, Diego Hernan

Get full text

Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines? by Aghel, Nazanin, Delgado, Diego Hernan, Lipton, Jeffrey Howard

“…Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML). Although these treatments have changed the natural…”
Get full text

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance by Aghel, Nazanin, Delgado, Diego Hernan, Lipton, Jeffrey Howard

“…Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment and outcomes of chronic myeloid leukemia (CML). Despite their significant impact on the…”
Get full text

The Added Value of Exercise Variables in Heart Failure Prognosis by Alba, A.C, Adamson, M.W, MacIsaac, J, Lalonde, S.D, Chan, W.S, Delgado, D.H, Ross, H.J

“…Highlights • This study shows that peak VO2 , OUES, and VE /VCO2 slope are independent predictors of HF prognosis when analyzed in association with recognized…”
Get full text

Are endothelial progenitor cells a prognostic factor in patients with heart failure? by Alba, Ana Carolina, Delgado, Diego Hernan, Rao, Vivek, Walter, Stephen, Guyatt, Gordon, Ross, Heather Joan

“…For the last two decades, endothelial progenitor cells (EPCs) have been proposed as a novel prognostic marker and potential therapeutic target in patients with…”
Get more information